GT Biopharma Inc (GTBP)

[scoot27]

All I can share is a few facts.

About to do second reverse split in two years, down about 98.7% since the first reverse split, down 99.9 from its highs a couple of years ago.

Down 80% this year alone, due to heavy dilution, with the company issuing stock to pay off debt. Now that they don't have enough stock to issue to pay off more debt, the board is authorizing more stock that can be issued at when the second reverse split occurs. I would expect more dilution since they have a lot of debt, hardly any cash and they are at least a year and half from earning revenue (assuming their lead drug makes it through Phase III).

All of this is in my opinion only, do your own research and I would recommend not trusting what you read on the message boards.